RETRACTION: CircPTPRM Accelerates Malignancy of Papillary Thyroid Cancer via miR‐885‐5p/DNMT3A Axis
Journal of Clinical Laboratory Analysis, Volume 40, Issue 1, January 2026.RETRACTION: D. Chen, X. Jiang, H. Luo, Q. Hua, and F. Zhang, “CircPTPRM Accelerates Malignancy of Papillary Thyroid Cancer via miR‐885‐5p/DNMT3A Axis,” Journal of Clinical Laboratory Analysis 36, no. 10 (2022): e24688, https://doi.org/10.1002/jcla.24688.
wiley +1 more source
miR-551b and SEMA3D as Potential Therapeutic Targets in Papillary Thyroid Cancer
, 2016 Xiaoli Zhang +3 more
openalex +1 more source
Expression of ANGPTL2 and its impact on papillary thyroid cancer [PDF]
, 2019 Longyan Yang +7 more
openalex +1 more source
Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
, 2015 Gang Dong +3 more
openalex +1 more source
Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment? [PDF]
, 2014 CALO', PIETRO GIORGIO +6 more
core +1 more source
Successful Salvage of Four Cases of Unresectable Papillary Thyroid Cancer Following Lenvatinib Administration [PDF]
Kodai Tsuchida +7 more
openalex +1 more source
Perinatal Exposures to Ambient Fine Particulate Matter and Outdoor Artificial Light at Night and Risk of Pediatric Papillary Thyroid Cancer [PDF]
Nicole C. Deziel +10 more
openalex +1 more source
A patient with newly diagnosed breast cancer found to have mosaic TP53 likely pathogenic variant
CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Hetal D. Mistry +8 more
wiley +1 more source
Long noncoding RNA LINC02432 inhibits papillary thyroid cancer via promoting ferroptosis [PDF]
Yilin Zhang +10 more
openalex +1 more source